Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Bruix, Jordi Qin, Shukui Merle, Philippe Granito, Alessandro Huang, Yi-Hsiang Bodoky, György Pracht, Marc Yokosuka, Osamu Rosmorduc, Olivier Breder, Valeriy Gerolami, René Masi, Gianluca Ross, Paul J Song, Tianqiang Bronowicki, Jean-Pierre Ollivier-Hourmand, Isabelle Kudo, Masatoshi Cheng, Ann-Lii Llovet, Josep M Finn, Richard S LeBerre, Marie-Aude Baumhauer, Annette Meinhardt, Gerold Han, Guohong